Immediate evolocumab after a heart attack improves LDL-cholesterol goals but not early cardiovascular outcomes

Immediate initiation of evolocumab aft a bosom onslaught importantly improved low-density lipoprotein cholesterin (LDL-C) extremity achievement, but an aboriginal simplification successful all-cause decease oregon unplanned cardiovascular hospitalization was not observed compared with modular care. These were the main findings of the AMUNDSEN proceedings presented successful a Hot Line league astatine ESC Congress 2026 and published simultaneously successful JAMA.